BIOSECURE Act: Companies turn to US manufacturers
During Covid-19, US companies had to find onshore manufacturing. Experts believe this may also be an answer to the BIOSECURE Act.
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
Repare Therapeutics doses first subject in Phase I solid tumour trial
Capricor touts long-term efficacy of DMD therapy ahead of FDA application
Mater Research initiates combined Covid-flu vaccine trial
Astella’s iota receives FDA go-ahead for bladder implant trial
CEPI to initiate Phase II trials of a Rift Valley fever vaccine in Kenya
Abbott advances two pulsed field ablation studies for AFib treatment
Analysis
View More
Themes
View MoreRivanna starts trial for AI-enabled Accuro XV imaging system
The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
NIH selects Emergex’s T cell vaccine for trials under Project NextGen
Exscientia outline robot and AI use in drug discovery workflow
Perimeter completes enrolment for AI-assisted breast imaging trial
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule